Journal article
Exploiting real-time genomic surveillance data to assess 4CMenB meningococcal vaccine performance in Scotland, 2015 to 2022
- Abstract:
-
The United Kingdom implemented the first national infant immunization schedule for the meningococcal vaccine 4CMenB (Bexsero) in September 2015, targeting serogroup B invasive meningococcal disease (IMD). Bexsero contains four variable subcapsular proteins, and postimplementation IMD surveillance was necessary, as nonhomologous protein variants can evade Bexsero-elicited protection. We investigated postimplementation IMD cases reported in Scotland from 1 September 2015 to 30 June 2022. Pat...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.1MB, Terms of use)
-
(Preview, Figures/images, pdf, 66.6KB, Terms of use)
-
(Preview, Supplementary materials, pdf, 261.6KB, Terms of use)
-
- Publisher copy:
- 10.1128/mbio.00499-23
Authors
Funding
Bibliographic Details
- Publisher:
- American Society for Microbiology
- Journal:
- mBio More from this journal
- Volume:
- 14
- Issue:
- 2
- Publication date:
- 2023-04-10
- Acceptance date:
- 2023-03-06
- DOI:
- EISSN:
-
2150-7511
- ISSN:
-
2161-2129
Item Description
- Language:
-
English
- Keywords:
- Pubs id:
-
1331546
- Local pid:
-
pubs:1331546
- Deposit date:
-
2023-03-07
Terms of use
- Copyright holder:
- Rodrigues et al.
- Copyright date:
- 2023
- Rights statement:
- © 2023 Rodrigues et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record